Literature DB >> 6832622

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.

T Lind, C Cederberg, G Ekenved, U Haglund, L Olbe.   

Abstract

The effect of oral omeprazole on pentagastrin stimulated gastric acid secretion was studied in 11 healthy subjects. Doses of 20-80 mg produced dose dependent inhibition of acid secretion, with total suppression at the highest dose. Omeprazole was absorbed and eliminated from plasma rapidly and the inhibitory effect was related to the area under the plasma concentration time curve. The duration of action was long and single doses of 20 and 40 mg reduced acid secretion significantly for one and three days, respectively. Omeprazole in a dose of 15 mg given once daily for five days, suppressed acid secretion continuously, the inhibitory effect stabilising after three days at a predose inhibition of about 30% and a postdose inhibition of about 80%.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832622      PMCID: PMC1419951          DOI: 10.1136/gut.24.4.270

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  5 in total

1.  A nonelectrogenic H+ pump in plasma membranes of hog stomach.

Authors:  G Sachs; H H Chang; E Rabon; R Schackman; M Lewin; G Saccomani
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

2.  Properties of a new class of gastric acid inhibitors.

Authors:  L Olbe; T Berglindh; B Elander; H Helander; E Fellenius; S E Sjöstrand; G Sundell; B Wallmark
Journal:  Scand J Gastroenterol Suppl       Date:  1979

3.  Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.

Authors:  E Fellenius; T Berglindh; G Sachs; L Olbe; B Elander; S E Sjöstrand; B Wallmark
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

4.  Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.

Authors:  W Domschke; G Lux; S Domschke
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

5.  Characterization of gastric mucosal membranes. X. Immunological studies of gastric (H+ + K+)-ATPase.

Authors:  G Saccomani; H F Helander; S Crago; H H Chang; D W Dailey; G Sachs
Journal:  J Cell Biol       Date:  1979-11       Impact factor: 10.539

  5 in total
  126 in total

1.  Age-related differences in the pharmacokinetics and pharmacodynamics of lansoprazole.

Authors:  Z Hussein; G R Granneman; D Mukherjee; E Samara; D L Hogan; M A Koss; J I Isenberg
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

2.  Dose ranging study of lansoprazole, a new proton pump inhibitor, in patients with high gastric acid secretion.

Authors:  I Berlin; P Molinier; A Duchier; A Cournot; J Durrel; F Dellatolas; J Duchier
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Pharmacokinetic study of omeprazole in elderly healthy volunteers.

Authors:  S Landahl; T Andersson; M Larsson; B Lernfeldt; P Lundborg; C G Regårdh; E Sixt; I Skånberg
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

4.  A lyophilized aqueous extract of Maytenus ilicifolia leaves inhibits histamine-mediated acid secretion in isolated frog gastric mucosa.

Authors:  Patrícia Maria Ferreira; César Nonato de Oliveira; Alaide Braga de Oliveira; Miguel José Lopes; Fernando Alzamora; Maria Aparecida Ribeiro Vieira
Journal:  Planta       Date:  2004-03-10       Impact factor: 4.116

5.  Pharmacokinetics of various single intravenous and oral doses of omeprazole.

Authors:  T Andersson; C Cederberg; C G Regårdh; I Skånberg
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Influence of acid secretory status on absorption of omeprazole from enteric coated granules.

Authors:  T Andersson; R Bergstrand; C Cederberg
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

7.  Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients.

Authors:  Géraldine Pettersen; Mohamad-Samer Mouksassi; Yves Théorêt; Line Labbé; Christophe Faure; Bao Nguyen; Catherine Litalien
Journal:  Br J Clin Pharmacol       Date:  2008-10-23       Impact factor: 4.335

8.  A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects.

Authors:  M Hassan-Alin; T Andersson; M Niazi; K Röhss
Journal:  Eur J Clin Pharmacol       Date:  2004-12-01       Impact factor: 2.953

9.  Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.

Authors:  C W Howden; J A Forrest; J L Reid
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

10.  Omeprazole in duodenal ulceration: acid inhibition, symptom relief, endoscopic healing, and recurrence. Cooperative study.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.